Sibutramine-associated psychotic episode.
Taflinski
T
T
Chojnacka
J
J
D000328:Adult; D014150:Antipsychotic Agents / Q000627:therapeutic use; D001067:Appetite Depressants / Q000009:adverse effects*; D003503:Cyclobutanes / Q000009:adverse effects*; D005260:Female; D006801:Humans; D009765:Obesity / Q000188:drug therapy; D010259:Paranoid Disorders / Q000139:chemically induced* / Q000188:drug therapy; D010464:Perazine / Q000627:therapeutic use; D011605:Psychoses, Substance-Induced / Q000188:drug therapy / Q000209:etiology*
D014150:Antipsychotic Agents; D001067:Appetite Depressants; D003503:Cyclobutanes; D010464:Perazine; C058254:sibutramine